EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blood DNA methylation and breast cancer risk: a prospective nested case–control study

Juan Rodriguez, Felix Grassmann, Damien Kaukonen, Sara Hägg, Keith Humphreys, Mikael Eriksson, Yuqi Zhang, Katharina Morawitz, Marike Gabrielson, Per Hall, Kamila Czene

eBioMedicine · 2026-07 · 129 · 106352

DOI: 10.1016/j.ebiom.2026.106352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eBioMedicine, 2026-07. Verfasst von Juan Rodriguez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: juan.rodriguez@ki.se. Hauptthemen laut MEDLINE: DNA Methylation, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stockholm Cancer Society, Swedish Research Council, Brandenburg State Ministry of Science Research and Culture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationBreast NeoplasmsBiomarkers, TumorHumansFemaleCase-Control StudiesMiddle AgedProspective StudiesCpG IslandsRisk FactorsAgedGenetic Predisposition to DiseaseSwedenGenetic Risk Score

Stichwörter der Autor:innen

Blood-based biomarkersBreast cancerDNA methylationMRSRisk prediction

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: juan.rodriguez@ki.se.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Health and Medical University, Potsdam, Germany.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Health and Medical University, Potsdam, Germany.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Södersjukhuset, Stockholm, Sweden.

Förderung

  • Stockholm Cancer Society
  • Swedish Research Council
  • Brandenburg State Ministry of Science Research and Culture
  • Swedish Cancer Society
  • Region Stockholm
  • Erling-Persson Foundation

Zitieren

APA

Rodriguez, J., Grassmann, F., Kaukonen, D., Hägg, S., Humphreys, K., Eriksson, M., Zhang, Y., Morawitz, K., Gabrielson, M., Hall, P., & Czene, K. (2026). Blood DNA methylation and breast cancer risk: a prospective nested case–control study. eBioMedicine, 129, 106352. https://doi.org/10.1016/j.ebiom.2026.106352

Vancouver

Rodriguez J, Grassmann F, Kaukonen D, Hägg S, Humphreys K, Eriksson M, et al. Blood DNA methylation and breast cancer risk: a prospective nested case–control study. eBioMedicine. 2026;129:106352. doi:10.1016/j.ebiom.2026.106352

BibTeX
@article{Rodriguez2026,
  author = {Rodriguez, Juan and Grassmann, Felix and Kaukonen, Damien and Hägg, Sara and Humphreys, Keith and Eriksson, Mikael and Zhang, Yuqi and Morawitz, Katharina and Gabrielson, Marike and Hall, Per and Czene, Kamila},
  title = {Blood DNA methylation and breast cancer risk: a prospective nested case–control study},
  journal = {eBioMedicine},
  year = {2026},
  volume = {129},
  pages = {106352},
  doi = {10.1016/j.ebiom.2026.106352}
}
Kostenlos starten →